Skip to main content
. 2024 Nov 20;24:417. doi: 10.1186/s12876-024-03518-y

Table 1.

Demographic and clinical data of IBD patients and controls

CD(n = 30) UC(n = 30) controls (n = 30)
Male (n, (%)) 19 (63.3) 16 (53.3) 13 (43.3)
Age(years, Inline graphic) 37.4 ± 12.5 47.9 ± 17.1 43 ± 14.9
BMI (kg/m2, Inline graphic) 21.4 ± 3.6 20.6 ± 3.0 22.1 ± 2.7
Smoking(n, (%)) 4(13.3) 4(13.3) 5(16.7)
Alcohol(n, (%)) 4(13.3) 3(10.0) 5(16.7)
hsCRP(mg/L, Me(Q1,Q3)) 6.36 (2.02,12.45)* 3.91 (0.61,18.83) * 1.57 (0.00,3.24)
ESR(mm/h, Me(Q1,Q3)) 14.5 (4.7,34.0) 13.5(4.7,26.5) -
TG(mmol/L, Me(Q1,Q3)) 1.08 (0.84,1.22) 0.98 (0.67,1.51) 1.03 (0.93,1.41)
TC (mmol/L, Me(Q1,Q3)) 3.79 (3.49,4.34) 4.08 (3.46,4.76) 3.28 (2.98,2.68)
LDL (mmol/L, Me(Q1,Q3)) 2.20 (1.86,2.56) 2.20 (1.78,2.75) 2.22 (1.88,2.99)
Hb (g/L, Me(Q1,Q3)) 131 (119,147) 131 (117,145) 139 (131,147)
FC-positive (n, (%)) 13 (43.3) 18 (60.0) -
CDAI/Mayo score(Me(Q1,Q3)) 217.8(200.7,235.0) 9(7,10)
Lesion sites (n, (%))
L1/E1 4 (13.3) 2 (6.7) -
L2/E2 6 (20.0) 12 (40.0) -
L3/E3 20 (66.7) 16 (53.3) -
Disease behavior (n (%))
B1 13 (43.3) - -
B2 15 (50.0) - -
B3 2 (6.7) - -

* means p < 0.05